Literature DB >> 8899561

Purification and characterization of human heart fatty acid ethyl ester synthase/carboxylesterase.

P S Bora1, B L Guruge, D D Miller, B R Chaitman, M S Ruyle.   

Abstract

Fatty acid ethyl ester synthase metabolizes ethanol non-oxidatively in those extrahepatic organs most commonly damaged by alcohol abuse. This study was designed to purify human myocardial fatty acid ethyl ester synthase (FAEES)/carboxylesterase from human heart. The enzyme was purified to homogeneity after chromatography over DEAE-cellulose, Sephadex G-100 and hydroxylapatite. The homogenous enzyme, 62 kDa, has both synthase and carboxylesterase activities. The N-terminal amino acid sequence of the first 17 residues of the purified enzymes were 88% homologous to that of the carboxylesterase from rat liver and adipose tissue. Antibody was raised against pure synthase/carboxylesterase cross-reacted with human cytosolic and microsomal fractions. With a constant oleic acid concentration of 0.25 mM, a calculated apparent Km and Vmax for ethanol were 0.30 M and 3700 nmol/mg protein/h., respectively. With constant ethanol concentrations of 1.2 M, the activity increased with the concentration of oleic acid to 0.17 mM, plateau to 0.25 mM. Because synthase/carboxylesterase esterifies free fatty acids with ethanol to produce its esters with potentially toxic effects, it may now be feasible to establish a link between alcohol consumption and end-organ damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899561     DOI: 10.1006/jmcc.1996.0195

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

1.  A novel lactone-forming carboxylesterase: molecular identification of a tuliposide A-converting enzyme in tulip.

Authors:  Taiji Nomura; Shinjiro Ogita; Yasuo Kato
Journal:  Plant Physiol       Date:  2012-04-02       Impact factor: 8.340

2.  Mutagenesis and characterization of specific residues in fatty acid ethyl ester synthase: a gene for alcohol-induced cardiomyopathy.

Authors:  P S Bora; D D Miller; B R Chaitman
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 3.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

4.  Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system.

Authors:  Annelot C M van Esbroeck; Zoltan V Varga; Xinyu Di; Eva J van Rooden; Viktória E Tóth; Zsófia Onódi; Mariusz Kuśmierczyk; Przemyslaw Leszek; Péter Ferdinandy; Thomas Hankemeier; Mario van der Stelt; Pál Pacher
Journal:  Pharmacol Res       Date:  2019-11-30       Impact factor: 7.658

5.  Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.

Authors:  Toshiyuki Harada; Yoshiaki Nakagawa; Randy M Wadkins; Philip M Potter; Craig E Wheelock
Journal:  Bioorg Med Chem       Date:  2008-11-09       Impact factor: 3.641

Review 6.  Nonoxidative ethanol metabolism in humans-from biomarkers to bioactive lipids.

Authors:  Christoph Heier; Hao Xie; Robert Zimmermann
Journal:  IUBMB Life       Date:  2016-10-06       Impact factor: 3.885

7.  Monoacylglycerol Lipases Act as Evolutionarily Conserved Regulators of Non-oxidative Ethanol Metabolism.

Authors:  Christoph Heier; Ulrike Taschler; Maja Radulovic; Philip Aschauer; Thomas O Eichmann; Susanne Grond; Heimo Wolinski; Monika Oberer; Rudolf Zechner; Sepp D Kohlwein; Robert Zimmermann
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

8.  Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors.

Authors:  Karl Emil Nelveg-Kristensen; Peter Bie; Laura Ferrero; Ditte Bjerre; Niels E Bruun; Martin Egfjord; Henrik B Rasmussen; Peter R Hansen
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 9.  Human carboxylesterases: a comprehensive review.

Authors:  Dandan Wang; Liwei Zou; Qiang Jin; Jie Hou; Guangbo Ge; Ling Yang
Journal:  Acta Pharm Sin B       Date:  2018-06-25       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.